Filing Details
- Accession Number:
- 0000899243-22-037146
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-29 17:43:34
- Reporting Period:
- 2022-11-25
- Accepted Time:
- 2022-11-29 17:43:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1596946 | Quotient Ltd | QTNT | In Vitro & In Vivo Diagnostic Substances (2835) | 264719797 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1823186 | Isabelle Buckle | C/O Quotient Limited, Business Park Terre Bonne, Route De Crassier 13 Eysins V8 1262 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2022-11-25 | 1,014 | $0.88 | 2 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Ordinary Share Option (Right to Buy) | $192.40 | 2030-09-01 | 519 | 519 | Direct | |
| Ordinary Shares | Ordinary Share Option (Right to Buy) | $192.40 | 2030-09-01 | 54 | 54 | Direct | |
| Ordinary Shares | Ordinary Share Option (Right to Buy) | $182.00 | 2030-10-31 | 340 | 340 | Direct | |
| Ordinary Shares | Ordinary Share Option (Right to Buy) | $101.20 | 2031-10-31 | 601 | 601 | Direct | |
| Ordinary Shares | Restricted Stock Units | $0.00 | 1,750 | 1,750 | Direct | ||
| Ordinary Shares | Ordinary Share Option (Right to Buy) | $5.20 | 2032-10-31 | 1,000 | 1,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2030-09-01 | 519 | 519 | Direct |
| 2030-09-01 | 54 | 54 | Direct |
| 2030-10-31 | 340 | 340 | Direct |
| 2031-10-31 | 601 | 601 | Direct |
| 1,750 | 1,750 | Direct | |
| 2032-10-31 | 1,000 | 1,000 | Direct |
Footnotes
- Restricted Stock Units convert into ordinary shares on a one-for-one basis.
- 173 options vested on September 1, 2022 and remain exercisable, and the remaining 173 options will vest on September 2, 2023.
- All 54 options have vested and remain exercisable.
- All 340 options have vested and remain exercisable.
- All 601 options have vested and remain exercisable.
- On October 31, 2022, the Reporting Person was granted 1,750 restricted stock units, vesting in four equal installments on January 31, 2023, April 30, 2023, July 31, 2023 and October 31, 2023.
- The options vest and become exercisable on October 31, 2023.
Billionaire Hedge Funds
